Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (130)

Latest Posts

About This Stock More About This Stock
Johnson & Johnson: One Of The Best Dividend Aristocrats For Retirement Portfolios
Article By: Simply Safe Dividends
Saturday, June 24, 2017 1:58 PM EDT
Johnson & Johnson’s enormous scale allows it access to one of the industry’s largest R&D budgets, $9.1 billion in the past 12 months, or about 13% of revenue.
In this article: JNJ Also: PFE
Read
Johnson & Johnson Diabetes Data Seen As Boon For Eli Lilly
Article By: The Fly
Tuesday, June 13, 2017 5:01 PM EDT
Johnson & Johnson reported results from the "CANVAS" trials of its already-approved SGLT-2 inhibitor Invokana, saying the drug significantly lowered risk of cardiovascular death.
In this article: JNJ Also: MRK, LLY
Read
Biotech Avoids Tech Wreck Of June 9
Article By: Rod Raynovich
Monday, June 12, 2017 1:48 AM EDT
A big part of 2017 investing strategy will be picking the right sector. Healthcare appears to offer modest returns with a dividend play.
In this article: BAC, BMY, JNJ, MRK, PFE, IBB, AAPL, AMZN, GILD, NFLX, NVDA, TSLA, SMH, XBI, XLE, XLF, XLV, FB, ABBV, GOOGL, BLUE
Read
Week In Review: China Life Science Venture Tie-Up, WuXi And Frontline Merge
Article By: ChinaBio® Today
Saturday, May 27, 2017 6:08 PM EDT
Two prominent China-US healthcare investment firms plan to join forces. WuXi Healthcare Ventures and Frontline BioVentures will merge to form 6 Dimensions Capital.
In this article: JNJ, ABBV
Read
EC HH The Active Versus Passive Performance Debate Is Nonsensical
Article By: Chuck Carnevale
Thursday, May 18, 2017 10:23 AM EDT
One of the most hotly contested debates in finance is the argument over which is better – active or passive investing.
In this article: KMB, SPX, SO, JNJ
Read

PARTNER HEADLINES

Latest Tweets for $JNJ

No tweets yet!